Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | -7.69% | 0.00% | -11.11% |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
EasyDNA
88.6
%
| 6 | 88.3 % | 8 | 88.6 % | +28.28% |
AffinityDNA
10.9
%
| - | - | 1 | 10.9 % | - |
GeneType/Corporate
0.5
%
| 1 | 11.7 % | 0 | 0.5 % | -94.52% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe, Middle East and Africa
51.7
%
| 3 | 36.8 % | 4 | 51.7 % | +79.69% |
America and Canada
25.8
%
| 2 | 33.5 % | 2 | 25.8 % | -1.42% |
Asia Pacific
18.7
%
| 2 | 27.8 % | 2 | 18.7 % | -13.91% |
Latin America
3.7
%
| 0 | 1.9 % | 0 | 3.7 % | +149.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Simon Morriss
CEO | Chief Executive Officer | - | 01/21/01 |
Erika Spaeth
CTO | Chief Tech/Sci/R&D Officer | - | 01/16/01 |
Jerzy Muchnicki
BRD | Director/Board Member | - | 31/18/31 |
Carl Stubbings
PRN | Corporate Officer/Principal | - | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 24/14/24 | |
Chairman | - | 31/18/31 | |
Jerzy Muchnicki
BRD | Director/Board Member | - | 31/18/31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 115,417,246 | 101,762,304 ( 88.17 %) | 0 | 88.17 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-11.11% | 10.48M | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.23% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- GTG Stock
- Company Genetic Technologies Limited